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Abstract
miRNAs are small regulatory RNAs that, due to their considerable potential to target a wide range of mRNAs, are implicated
in essentially all biological process, including cancer. miR-10a is particularly interesting considering its conserved location in
the Hox cluster of developmental regulators. A role for this microRNA has been described in developmental regulation as
well as for various cancers. However, previous miR-10a studies are exclusively based on transient knockdowns of this miRNA
and to extensively study miR-10a loss we have generated a miR-10a knock out mouse. Here we show that, in the Apcmin
mouse model of intestinal neoplasia, female miR-10a deficient mice develop significantly more adenomas than miR-10+/+
and male controls. We further found that Lpo is extensively upregulated in the intestinal epithelium of mice deprived of
miR-10a. Using in vitro assays, we demonstrate that the primary miR-10a target KLF4 can upregulate transcription of Lpo,
whereas siRNA knockdown of KLF4 reduces LPO levels in HCT-116 cells. Furthermore, Klf4 is upregulated in the intestines of
miR-10a knockout mice. Lpo has previously been shown to have the capacity to oxidize estrogens into potent depurinating
mutagens, creating an instable genomic environment that can cause initiation of cancer. Therefore, we postulate that Lpo
upregulation in the intestinal epithelium of miR-10a deficient mice together with the predominant abundance of estrogens
in female animals mainly accounts for the sex-related cancer phenotype we observed. This suggests that miR-10a could be
used as a potent diagnostic marker for discovering groups of women that are at high risk of developing colorectal
carcinoma, which today is one of the leading causes of cancer-related deaths.
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Introduction
A growing number of studies show the importance of aberrant
miRNA expression in cancer. Although miRNA profiling studies
have proven useful in defining signatures of cancer-deregulated
miRNAs with diagnostic and/or prognostic value [1,2], establish-
ing casual relationships is not always possible. Altered miRNA
expression in cancer can arise from genomic abnormalities but
also by alteration of upstream regulators of miRNA expression
and/or maturation, including epigenetic silencing [3].
The miR-10 miRNA family members are encoded in evolu-
tionarily conserved loci within the Homeobox (Hox) gene clusters
of developmental regulators [4,5]. Co-expression of miR-10 and
Hox genes during development [6,7] and experimental evidence of
miR-10 targeting of HOX transcripts [8–10] has suggested a role
for this miRNA family in development. Mammalian miR-10a and
miR-10b are located upstream from HoxB4 and HoxD4 respectively
and they present a very high degree of sequence conservation,
differing at their eleventh nucleotide only (U and A respectively),
which thermodynamically enables them to target a fully overlap-
ping set of mRNAs [11,12]. Importantly, both up- and downreg-
ulation of miR-10 has been reported in several cancers and
although the number of studies where such deregulation was
causally linked to the pathogenesis of cancer remains scarce (for a
review, see [4]), some miR-10 targets have been demonstrated to
be mechanistically linked to metastasis, invasion and migration as
well as cell proliferation [9,10,13–16].
Colorectal cancer is the second most commonly diagnosed
cancer in women and it is one of the leading causes of cancer-
related deaths in the world [17]. Colon cancer arises from the
epithelial cells of the lumen of the colon where benign
adenomatous polyps are established as an initial step. These
further progresses into more advanced adenomas showing high-
grade dysplasia and can ultimately evolve into invasive cancer.
One of the most studied causes of colon cancer is aberrant
signaling of the evolutionary conserved Wnt pathway, which is
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tightly regulated during development and crucial for adult tissue
homeostasis in the intestinal tract [18]. The tumor suppressor
Adenomatous polyposis coli (Apc) gene is an essential negative
regulator of the Wnt pathway and loss of function of this gene is
associated with a great majority of colorectal cancers [19–21].
Clinically, colon cancer is categorized in four stages (I to IV)
corresponding to its degree of progression [22,23]. Chromosomal
instability, DNA-repair and aberrant DNA methylation have been
shown to be important for the development and progression of
colon cancer (for a review, see [22]). Interestingly, miR-10a was
previously found to be moderately up regulated in solid tumors
and stage II but not in stage I cancers in the colon [24,25].
Here we have generated a miR-10a knock out (KO) mouse and
crossed it with the ApcMin colon cancer mouse model of familial
adenomatous polyposis. Interestingly, only in female mice the
specific lack of miR-10a sensitized the intestinal epithelium to
increased tumor development. Lactoperoxidase (Lpo) was strikingly
deregulated between miR-10a KO and WT intestines and our data
suggests that LPO is an indirect target of miR-10a, being directly
regulated by the transcription factor and primary miR-10a target
KLF4. Compellingly, Lpo has previously been reported to have
the capacity to oxidize estrogenic substrates into potent depurinat-
ing mutagens, which are known to contribute to the initiation of
cancer.
Results
Generation of miR-10a KO mice
To assess the physiological role and pathophysiological signif-
icance of miR-10a, we generated a null allele of miR-10a by gene
targeting. The targeted locus consisted of a loxP-flanked neo
selection cassette, which replaced the 70 central nucleotides of the
pre-miRNA sequence of miR-10a (Figure 1A). The targeting vector
was introduced into embryonic stem (ES) cells, selected with G418
and correctly targeted clones with the genotype miR-10a+/neo were
identified by Southern blotting (data not shown). Chimeric mice
were generated that transmitted the mutated allele through the
germ line. All offspring were genotyped and verified by PCR
(Figure 1B). Breeding of miR-10a+/neo mice to a mouse strain
holding an ubiquitously expressed Cre recombinase transgene [26]
resulted in deletion of the miR-10a genomic sequence and its
replacement by a residual LoxP site, yielding mice with the miR-
10a+/2 genotype (Figure 1B). Mice carrying the miR-10a floxed
allele (miR-10a2) were intercrossed with C57BL/6 mice for at least
7 generations before generating experimental cohorts.
Interbreeding of heterozygous miR-10a+/2 mice produced
homozygous null (miR-10a2/2) offspring at the expected Mende-
lian ratios (Figure S1A). These mice were indistinguishable from
littermate controls in terms of growth and development (Figure
S1B) and did not show decreased survival or an increased
incidence of spontaneous tumor development compared to WT
mice by 2 years of age. Likewise, gross pathological examination of
the major organs revealed no differences and analyses of embryo
fibroblast cultures did not show differences in proliferation rates or
time to replicative senescence (data not shown). To confirm that
the mutant allele was null, quantitative RT-PCR was performed
on RNAs extracted from the intestines of WT and homozygous
(miR-10a2/2) mutant mice (Figure S1C). qRT-PCR using specific
primers for miR-10b on the same RNA showed no significant
Author Summary
Posttranscriptional regulation by microRNA molecules
constitutes an important mechanism for gene regulation
and numerous studies have demonstrated a correlation
between deregulated microRNA levels and diseases, such
as cancer. However, genetics studies linking individual
microRNAs to the etiology of cancer remain scarce. Here,
we provide causal evidence for the involvement of the
conserved microRNA miR-10a in the development of
intestinal adenomas in the face of activated Wnt signaling.
Interestingly, we find that loss of miR-10a mediates an
increase in intestinal adenomas in female mice only and
delineate the pathway to involve aberrant upregulation of
the miR-10a target Klf4 and subsequent transcriptional
activation of the Lpo gene encoding the antibacterial
protein Lactoperoxidase. Lpo, in turn, has previously been
demonstrated to oxidize estrogens into DNA-damaging
mutagens.
Figure 1. Generation of miR-10a KO mice. (A) Schematic representation of the miR-10a WT locus, the targeting construct used for inactivation
and the final miR-10a null allele. The targeting construct (TC) harbored a miR-10a inactivated allele, where 70 nucleotides from the pre-miRNA
sequence were replaced with a neomycin resistance cassette (neo) flanked by loxP sites and long homologous regions for recombination. To obtain
the final miR-10a null allele (KO), the neomycin cassette was removed in the mouse germ line by breeding heterozygous mice to transgenic mice
harboring the Cre transgene. Arrowheads depict the sites recognized by different primers used in genotyping of mice. (B) Genotyping PCR of mice
with all different miR-10a genotypes generated. Primers L_chkinsrtmiR10a.5d and 10a.internal amplified a 273 bp fragment corresponding to the
miR-10 WT allele and 361 bp for the floxed miR-10a KO allele, L_chkinsrtmiR10a.5d and R_chkinsrtmiR10a.5 amplified 291 bp from the miR-10aneo
allele. The location of all these primers is depicted in (A).
doi:10.1371/journal.pgen.1003913.g001
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difference in the level of this close member of the miR-10 family,
suggesting no occurrence of dose-dependent compensation via
trans-regulation of miR-10b in the absence of miR-10a (Figure
S1D). HoxB4 is located 992 nucleotides downstream from the miR-
10a gene and the transcription of both genes has been proposed to
be co-regulated [6,7]. Deletion of miR-10a did not interfere with
transcription of HoxB4 since similar levels of HoxB4 mRNA were
detected by quantitative RT-PCR in intestinal samples (Figure
S1E).
miR-10a deficiency enhances intestinal tumorigensis in
female ApcMin mice
Since miR-10a inactivation alone did not give rise to increased
spontaneous tumor formation, we evaluated if the lack of this
miRNA could modify tumor formation upon an additional
oncogenic injury. Profiling of WT mouse tissues for miR-10a
and miR-10b revealed that miR-10a was relatively highly
expressed in the mouse intestinal tract (Figure S2). Furthermore,
profiling studies have shown that miR-10a expression is deregu-
lated in human colon cancer [9,24,25]. Therefore, the ApcMin
mouse model [27] was chosen to evaluate the role of miR-10a in
intestinal neoplasia development. ApcMin mice carry a mutation in
the murine homolog of the human APC gene [28] and develop
multiple intestinal tubular adenomas similar to those found in
patients with the familial adenomatous polyposis syndrome.
Furthermore, the ApcMin mouse model is frequently used to
evaluate the significance of genetic modifiers [29–32].
To examine the impact of disrupting miR-10a in ApcMin mice,
the miR-10a KO and ApcMin mouse strains (both in a C57BL/6
background) were intercrossed. Mice were sacrificed at around
140 days of age for tumor burden evaluation. Strikingly, the mean
tumor multiplicity in small intestines of miR-10a2/2;ApcMin female
mice (79.33, n= 15) was almost twice as high as in corresponding
miR-10a+/+;ApcMin age matched controls (41.95, n= 22)
(p = 0.0042) (Figure 2A). Tumor multiplicity (TM) and tumor
incidence (TI) in the large intestine were also higher in the female
mice lacking miR-10a (TM=2.40, TI = 72.2%), compared to
control (TM=0.82, TI = 54.2%) but those differences were less
significant or not significant, respectively (pTM=0.014; pTI = 0.38;
Figure 2B). Noteworthy, the miR-10a genotype did not affect
tumor multiplicity in ApcMin male mice irrespective of the anatomic
location (psmall intestine = 0.61, plarge intestine = 0.16; Figures 2A and
2B). The incidence of polyps in the large intestine of male mice
also remained unaffected (p= 0.30).
To examine the effect of miR-10a deficiency on tumor size, the
flat adenomas of the small intestine were measured at their largest
diameter, and this measure was used as indicator of tumor size. No
significant difference was observed in mean tumor diameters
between miR-10a2/2;ApcMin and miR-10a+/+;ApcMin control mice
irrespective of gender (p = 0.614 for males and p=0.071 for
females; Figure 2C).
Entire intestinal tracts were paraffin-embedded as ‘‘Swiss rolls’’
and hematoxylin and eosin (H&E) stained sections were examined
microscopically based on pathological criteria. Qualitatively,
compared to miR-10a+/+;ApcMin mice intestines, samples from
miR-10a2/2;ApcMin mice presented more frequently adenomas
with high-grade dysplasia and a higher incidence of tubulo-villous
adenomas, these differences were more evident in female mice
(Figure 2D). However, no invasive carcinomatous processes were
observed in any of the analyzed samples. The increased tumor
multiplicity and colonic epithelial dysplasia along with unaffected
adenoma sizes in the absence of miR-10a, suggest that miR-10a is
involved in the tumor initiation/promotion steps but not in
enhancing cell proliferation in the ApcMin model of intestinal
neoplasia [33,34]. However, due to ethical constraints, the mice
are sacrificed at a relatively young age and we cannot formally rule
out that an effect on tumor progression would be discernable in
the end-stage tumors.
Identification of miR-10a targets in the intestines of
female mice
miRNA exert their biological functions primarily by regulating
the translation and stability of targeted mRNAs [35,36]. Micro-
array analysis of deregulated transcripts upon alteration of
individual miRNAs in cells and tissues has been proven as a
useful tool for identifying direct and indirect miRNA targets
[37,38]. Therefore, colon mRNA expression was analyzed in miR-
10a KO and WT female mice using Affymetrix microarrays.
Although 452 transcripts were significantly deregulated in the miR-
10a KO samples compared to WT (P#0.05), the levels of up- or
downregulation were modest and only three protein coding genes
had false discovery rates (FDR) lower than 15% (Table S2). In
addition, we did not detect any enrichment for predicted miR-10a
targets among the deregulated transcripts. Although adaptation to
loss of miR-10a or functional redundancy by the remaining miR-
10b could account for the invariable levels of miR-10 intestinal
targets in the absence of miR-10a, low levels of mRNA
deregulation upon miRNA alterations have been previously
observed [39,40]. Furthermore, the variation inherent to tissue
samples may shadow a high deregulation within a specific cell type
of the tissue. With the exception of Lpo, qRT-PCR measurement
of selected transcripts, using independent sample sets, did not show
any consistent deregulation of genes identified by the microarray
as variant between genotypes. Transcript abundance of selected
oncogenes and tumor suppressors, relevant in intestinal tumori-
genesis or previously predicted as miR-10a targets but not detected
in the microarray, were also unchanged in miR-10a deficient
compared to WT intestines (Figure S3).
Lpo is a secondary target of miR-10a in the intestines of
female mice and in human cell lines
Interestingly, Lpo was identified as exceptionally highly
upregulated in the intestines of miR-10a KO female mice,
displaying a 9.44 fold increase in expression compared to WT
(p= 1.1e-6; adjusted for multiple testing). Lactoperoxidase nor-
mally plays a role in antimicrobial defense and removal of toxic
hydrogen peroxide [41,42]. However, this enzyme has also been
shown to catalyze the activation of endogenous and xenobiotic
compounds, such as estrogens and arylamines, into potent
depurinating mutagens [43–46]. By increasing genome instability,
LPO has been proposed to exert a pro-oncogenic role in tissues
like the mammary gland [43,47]. Given the importance of genome
stability in the initiation and progression of intestinal tumorigenesis
[48], a similar mechanism might be involved in the phenotype
observed in miR-10a2/2;ApcMin female mice, i.e. the upregulation
of Lpo in miR-10a KO mice would enhance estrogen oncogenic
activation, leading to a highly instable genomic environment.
qRT-PCR confirmed Lpo overexpression by 29-fold in female miR-
10a KO intestines compared to WT (Figure 3A). Similar degrees
of Lpo upregulation were obtained in male miR-10a KO mice (data
not shown). Accordingly, analysis of protein extracts from miR-10a
KO and WT intestines equally revealed a strong induction of Lpo
in miR-10a deficient samples (Figure 3B). In agreement with the
analysis of Lpo mRNA and Lpo protein level, a clear difference in
both intensity and distribution area of Lpo staining was observed
between miR-10a KO and WT mice (p#0.006, Pearson chi-square
test with exact probability). Consistently, all stained WT samples
miR-10a in Colon Cancer
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Figure 2. Disruption of miR-10a leads to enhanced intestinal tumorigenesis in ApcMin mice. Tumor multiplicity in the small (A) and large
intestines (B) of female and male miR-10a+/+;ApcMin (WT; n = 22 and n= 19 for each sex) and miR-10a2/2;ApcMin (KO; n = 15 and n= 16 for each sex)
mice; each dot represents data for one mouse. Mean adenoma multiplicities per mouse for each group were: WT= 41.95 and KO= 79.33 for female
miR-10a in Colon Cancer
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had faint Lpo signal in a limited area of the intestine thus scoring low
expression while the majority of miR-10a KO tissue samples had a
significantly more intense Lpo signal and a more widespread Lpo
expression pattern, thus scoring medium to high (Figure 3C and 3D).
No bona fide miR-10a binding sites could be identified in the 39
UTR of Lpo but cryptic sites in the 59 UTR and coding sequence
(CDS) carried significant complementarity to miR-10a (Figure
S4A). To determine whether Lpo was a direct target of miR-10a,
via the putative binding sites identified in the 59 UTR and the
CDS of the gene, luciferase reporters holding the 59 UTR, the
entire CDS or a fragment of the CDS containing the most potent
binding site were constructed. However, none of the reporters
mice and WT=50.37 and KO=55.19 for male mice in the small intestine and WT= 0.82 and KO= 2.40 for female mice and WT=1.47 and KO=2.44 for
male mice in the large intestine. * p = 0.014, ** p = 0.0042 (two-tailed t-test) (C) Size distribution of polyps in the small intestine of female and male
miR-10a+/+;ApcMin (WT; filled bars) and miR-10a2/2;ApcMin (KO; empty bars) mice. Mean tumor diameters were 1.01 and 1.04 mm for males WT and KO
respectively and 1.03 and 0.94 for females WT and KO respectively (p=0.782 and p= 0.4113, Wilcoxon rank sum test). (D) Left panel shows normal
appearing small intestine with characteristic villi and well-ordered distribution of goblet cells together with basal location of epithelial nuclei. Middle
panel is a typical example of a low-grade dysplasia in miR-10a+/+;ApcMin (WT) mice with accumulation of irregular goblet cells pattern (arrowheads)
and some loss of nuclear polarity (indicated by ‘‘+’’). Right panel shows a typical miR-10a2/2;ApcMin (KO) high-grade dysplasia with a large area of loss
of goblet cells, widespread loss of nuclear polarity, nuclear pleomorphism, and almost complete loss of villus organization (indicated by ‘‘*’’). Note the
transition from lower-grade dysplasia area with highly irregular goblet cell distribution (arrowheads). Scalebar = 100 mM. Whole intestines were
paraffin-embedded as ‘‘Swiss rolls’’, sectioned and stained with hematoxylin and eosin. All animals were in a B6 background and between 110 and
160 days of age.
doi:10.1371/journal.pgen.1003913.g002
Figure 3. Lpo is transcriptionally upregulated in the intestines ofmiR-10a deficient female mice. (A) LpomRNA is,29-fold upregulated in
intestines of miR-10a KO compared to WT mice as shown by qRT-PCR. Lpo mRNA levels are normalized to Actb and values6 SD are shown relative to
the first WT sample. (B) Western-blot from same tissue samples as in (A) confirming upregulation on protein level. Vinculin was used as loading
control. As evident from Lpo and Vinculin control as well as ponceau staining (now shown), sample 4 did not contain any protein for unknown
reason. (C) Representative immunohistochemistry staining of Lpo in miR-10a WT and KO intestine. Scale bar 100 mm. (D) Scoring of Lpo expression
level estimated by distribution and staining intensity in Lpo stained intestines of WT and miR-10a2/2 mice. Scoring is divided into low, medium or
high expression. Consistent with qRT-PCR and Western blotting analysis a significant difference (p#0.006, Pearson chi-square test with exact
probability) in Lpo expression is observed between the different genotypes.
doi:10.1371/journal.pgen.1003913.g003
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were affected by co-transfection with a miR-10a duplex (Figure
S4B), suggesting that the identified sites were not functional miR-
10a targets in this set-up. Further qRT-PCR analysis of Lpo
transcripts in intestinal samples using primers in intronic and
exonic sequence elements, revealed that the primary transcript of
Lpo was upregulated in miR-10a KO samples to similar levels as the
Lpo mRNA (Figure S4C and S4D), indicating that Lpo deregula-
tion is transcriptional. Altogether, these results suggest that Lpo is
not directly regulated by miR-10a via cognate interaction with
target sites in the mRNA but instead that Lpo is regulated at the
transcriptional level, probably by one or several primary targets of
miR-10a.
The miR-10a target Klf4 is upregulated in miR-10a KO
mice and induces transcription of LPO in vitro
We hypothesized that one or more transcription factors under
miR-10a regulation could be responsible for enhancing LPO
transcription. To identify such transcription factors, we scanned a
2 kb region upstream of the LPO transcription start site (TSS)
using Consite and Transfac databases for transcription factor
binding site motifs. From the obtained lists of transcription factors,
we extracted those that were predicted as putative miR-10a targets
by TargetScan [49] and pursued the analysis of one interesting
candidate: Kru¨ppel-like factor 4 (Klf4). Klf4, a zinc finger-type
transcription factor primarily expressed in the gastrointestinal
tract, is an important regulator of differentiation and cell growth
arrest of the colonic epithelium and was previously shown to be
regulated by miR-10a [50,51]. Upregulation of KLF4 has
formerly been observed in early stages of colon carcinoma
compared to normal mucosal levels [52]. Using an in vitro setup,
in the epithelial-like colon carcinoma cell line HCT-116, we
demonstrated a 50% reduction of KLF4 mRNA abundance upon
transfection with miR-10a (Figure 4A). Importantly, miR-10a
mediated repression of this target was also observed at the protein
level (Figure 4B). These results confirm KLF4 as a target of miR-
10a as previously described [50].
To investigate the link between KLF4 and LPO we cloned a
1 kb fragment upstream of the TSS of LPO, holding core promoter
elements, in front of a luciferase reporter. Co-transfection of this
reporter vector with a KLF4 overexpression plasmid in HCT-116
cells resulted in a robust upregulation of luciferase activity,
demonstrating the capacity of KLF4 to regulate LPO (Figure 4C
and 4D). Using siRNA-mediated knockdown of KLF4 we further
linked KLF4 to the regulation of LPO. Although these assays are
complicated by a cell density-dependent expression of LPO, we
found that knockdown of KLF4 in HCT-116 cells markedly
reduced LPO mRNA levels (Figure 4E).
Primary miRNA targets commonly show a relatively low degree
of regulation on mRNA level after depletion of the miRNA. It can
particularly be difficult to detect these changes in tissue samples
that already present a considerable variation in mRNA expression
between individuals and within different cell types of the tissue. In
these types of experiments it is therefore crucial to use a sufficiently
large population to reach statistical significance. In our microarray
Figure 4. Transcription factor KLF4 is regulated by miR-10a and can regulate the LPO promoter in vitro. HCT-116 cells were transfected
with a miR-10a duplex or control for 72 h. (A) Relative mRNA levels of KLF4 were measured by qRT-PCR and ACTB was used for normalization. Data are
shown as mean 6 S.D. of three replicates relative to the control and are representative of three independent experiments. * p,0.05 using a two-
tailed t-test. (B) Protein levels in miR-10a or control transfected cells were assessed by Western-blot using antibodies against KLF4. GAPDH was used
as loading control. (C) Western Blot showing the over expression from the pcDNA3.1-KLF4 vector. GAPDH was used as loading control. (D) Luciferase
reporter assay in HCT-116 cells (24 h) with pGL4-luc2 holding part of the LPO promoter (1 kb upstream TSS) or the pGL4-luc2 empty vector co-
transfected with a vector over-expressing KLF4 or a control vector (pcDNA3.1+). Data are shown as mean 6 S.D. of three replicates relative to the
pcDNA3.1 transfected control and are representative of eleven independent experiments. **** p,0.0001 using a two-tailed t-test. (E) HCT-116 cells
were transfected with KLF4 siRNA for 48 h or 72 h. Relative mRNA levels of LPO were measured by qRT-PCR and ACTB was used for normalization.
Data are shown as mean 6 S.D. of three replicates relative to the control and are representative of five independent experiments.
doi:10.1371/journal.pgen.1003913.g004
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experiment we used intestinal RNA from only 6 animals (miR-10a
KO; n=3 and WT; n= 3) and we hypothesized that the limited
population could account for the lack of detectable Klf4 de-
regulation. To increase the statistical power we measured intestinal
Klf4 mRNA levels from 16 miR-10a KO and 13 WT mice by
qRT-PCR and used four housekeeping genes for normalization.
The results showed a significant increase of Klf4 mRNA levels in
the miR-10a KO mice compared to the WT (Figure 5A).
Consistently, Klf4 stainings demonstrated a marked increase of
protein distribution and intensity in the mouse intestines of miR-
10a KO compared to WT (Figure 5B and 5C). Specificity of Klf4
staining was verified by an independent antibody (Abcam;
ab151733), which gave a similar expression pattern but resulted
in an overall weaker staining (data not shown). Hence, our in silico,
in vitro and in vivo results support the existence of a regulatory
network linking miR-10a to LPO via KLF4 and potentially other
transcription factors.
Discussion
The enormous gene regulatory potential of miRNAs is well
demonstrated by many studies showing that perturbed miRNA
expression is capable of affecting diverse cellular functions and
could ultimately cause disease, including cancer. However, it has
been suggested that miRNAs are primarily important in fine-
tuning mRNA expression and regulation executed by single
miRNAs are in most cases not sufficient to account for
pathological phenotypes [40,53]. In line with this, KO of
individual miRNAs in other animal models have revealed that
most are devoid of obvious phenotypes in the absence of additional
lesions or stresses [54,55]. Particular interest in the miR-10 family
members arises from their conserved genomic location in Hox
clusters and the increasing amount of evidence for their
implication in vertebrate biology and human disease [4]. Here
we addressed the question of the direct causal effect of miR-10a in
mammalian homeostasis, with a special focus on tumor develop-
ment, by generating miR-10a null mice.
Despite the body of evidence suggesting a role for miR-10 in Hox
regulation, the miR-10a2/2 mice showed an absence of major
developmental defects in the posterior trunk. Nevertheless, these
results are in agreement with the virtual lack of phenotypic
differences upon inhibition or overexpression of miR-10 during
zebra fish development [7]. In the case of miR-10a2/2 mice, the
lack of appreciable phenotypes could be explained by redundancy
and functional compensation by miR-10b, which levels remained
unaffected in miR-10a KO mice. A double inactivation of miR-10a
and miR-10b would allow disambiguation of the miR-10 role in
mammalian development.
Interestingly, one gene, Lactoperoxidase, consistently showed
an exceptionally high degree of deregulation in the intestines of
miR-10a deficient mice and to our knowledge this is the first report
correlating this gene in to a specific miRNA deficiency. Lpo is
mainly described as an antibacterial agent [41,56–58] exclusively
found in mucosal surfaces, including colon epithelium [59] and
exocrine secretions, like milk, tears, and saliva [60]. Importantly,
apart from its antimicrobial and hydrogen peroxide detoxification
activities, the role of LPO in carcinogenesis, particularly of the
mammary gland, has been intensively studied [43–45,61,62]. In
the reduction of peroxides, peroxidases can co-catalyze the
oxidation of aromatic and heterocyclic amines into electrophilic
metabolites with DNA binding capacity. In this way, Lactoper-
oxidase can catalyze the mutagenic activation of diverse endog-
enous and xenobiotic carcinogens, including natural [44,62] and
synthetic estrogens [63] as well as other synthetic or environmental
arylamines [43,45]. Lpo-mediated activation of such compounds
to the derivative quinones and semiquinones, has been shown to
induce the formation of the depurinating adducts N3Ade and
N7Gua in vitro and in vivo [44,45,61–63]. Subsequent error-prone
Figure 5. Klf4 is upregulated in miR-10a KO intestines. (A) mRNA levels of Klf4 were measured by qRT-PCR, Actb, Ubc, Hprt and 36b4 were used
for normalization. Data are shown as mean 6 S.D. of miR-10a KO (n= 16) and WT (n = 13) samples relative to an average of the controls. * p,0.05
using a Mann-Whitney test. (B) Representative immunohistochemistry staining of Klf4 in miR-10aWT (n= 5) and KO (n= 8) intestine. Scale bar 100 mm
(C) VisiomorphDP software scoring of Klf4 expression level estimated by distribution and staining intensity in Klf4 stained intestines of WT and miR-
10a KO mice. * p = 0.019, students t-test.
doi:10.1371/journal.pgen.1003913.g005
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base excision repair mechanisms may lead to mutations that can
be initiating events in breast, prostate and other types of cancer
[47]. Furthermore, estradiol and its catechol metabolites have
been shown to induce deletions and loss of heterozygosity in
epithelial breast cells resulting in an oncogenic transformed
phenotype [64].
Here we showed that Lpo is constitutively upregulated in the
intestinal epithelium of miR-10a2/2 mice and that when these
mice were crossed with ApcMin mice, females displayed a
significantly increased tumor burden in their intestinal epithelium.
We therefore propose that, in our set-up, upregulated Lpo induces
a mutagenic environment by increasing the oxidation of endog-
enous estrogens into their mutagenic derivatives, which subse-
quently leads to tumor formation. Consistently, this effect would
be sex-dependent, since estrogens are intrinsically at higher
concentrations in female relative to male mice. Similar to our
observations, other genetic studies with ApcMin mice have shown
that mutation of genes important for genome stability mainte-
nance, generally lead to an increase in adenoma multiplicities [65–
68].
Regarding the regulatory mechanism, the Lactoperoxidase
mRNA does not contain a miR-10a target site in its 39UTR.
Functional interactions between microRNAs and target sites in
other locations than the 39UTR have been described before,
including for miR-10a [69–74]. We therefore tested the function-
ality of putative miR-10a binding sites in the 59UTR and coding
region of LPO, however, our results led us to exclude the possibility
of a direct posttranscriptional regulation of LPO by miR-10a.
Instead we obtained evidence supporting a model where LPO
expression is regulated by the primary miR-10a target KLF4,
which is indeed over-expressed in the intestines of miR-10a KO
mice. Putative binding sites for this transcription factor are present
in the promoter of LPO, and transcriptional activation of LPO
could be reproduced in vitro by over-expressing KLF4. Moreover,
siRNA knockdown of KLF4 in HCT-116 cells resulted in
downregulation of LPO expression. Of notice, although not tested
experimentally, our bioinformatics approach identified other
transcription factors representing primary miR-10a targets with
putative binding sites in the LPO promoter, suggesting that
additional factors may participate in the indirect regulation of LPO
by miR-10a. This could, in part, explain the lack of detected
variation in the expression levels of direct miR-10a targets
(including Klf4) in our microarray experiments, since the
occurrence of small degrees of deregulation of primary targets
could have a measurable effect only upon convergence in a
secondary node. Alternative explanations could be evoked due to
the large variation inherent to tissue samples and the fact that the
colon tissue comprises a variety of cell types, such as epithelial,
luminal and muscular cells, which all have specific genetic
programs, thus very different transcriptomes. A change in mRNA
expression in one cell type could therefore be masked by the lack
of change in another, which could be due to alternative miRNA-
independent regulations or a potential rescue by miR-10b.
Nevertheless, transcriptomic, bioinformatics and biochemical
evidence allowed us to reveal a regulatory network where miR-
10a can indirectly alter the levels of LPO through KLF4.
Interestingly, intestinal miR-10a expression has previously been
shown to be downregulated by microbiota in mice [75], and
considering the antibacterial functions of Lpo in innate immunity,
it is alluring to suggest that miR-10 could function as the sensor of
immune stimuli in this environment where its downregulation
would induce Lpo as an antibacterial mechanism in normal
epithelium. However, having such a defense program constantly
activated in the presence of estrogen, as would be the case in the
miR-10a2/2 female mice, would ultimately be damaging for the
cells.
Our results are in contrast with reports of miR-10a upregulation
in colon cancer samples [24,25]. Such upregulation could
correspond to a consequence rather than a cause of oncogenic
transformation. This is enforced by the observation by Monzo et.
al. showing an upregulation of miR-10a in stage II but not in stage
I colon cancer samples [24], though the pathogenic role of miR-
10a upregulation in advanced colon cancer remains to be
elucidated. Moreover, Klf4 has been described to inhibit cell
growth and play a tumor suppressive rather than an oncogenic
role in colorectal cancer [51]. However, as suggested in our study,
oncogenic downregulation of miR-10a might be a very early event
promoting cellular transformation by a similar mechanism to the
one previously described for Lpo in mammary carcinoma [44].
Furthermore, and as mentioned above, not only Klf4 but likely
other primary targets of miR-10a are also involved in the
regulation of Lpo.
In summary, here we present evidence that miR-10a, through a
complex regulatory network involving the transcription factor
Klf4, can contribute to tumor formation in female mice. By the
indirect upregulation of Lpo levels in the intestinal epithelium,
miR-10a deficiency in these mice creates an environment where
estrogen could be transformed into potent depurinating mutagens
that can ultimately lead to the initiation of cancer and tumor
formation. Therefore we suggest that miR-10a may serve as a
potential diagnostic marker for identifying groups of women that
are at high risk of developing colorectal cancer.
Materials and Methods
Generation of miR-10a neo/+ ES cells
The miR-10a targeting plasmid was constructed using standard
recombineering techniques. R1-129 mouse ES cells were electro-
porated with the linearized targeting plasmid. G418 clones were
selected and grown independently. Each clone was genotyped by
southern blotting using the probes 59/PacI and 39/NsiI (Table S1)
and PacI- or NsiI-digested DNA to verify 59and 39recombination
respectively.
Ethics statement
All mice were handled according to good animal handling
practices and the animal experiments approved by the Danish
Animal Experiments Inspectorate.
Mice
miR-10a KO mice were generated as follows. ES cells from one
of the three screened and correctly targeted clones were
microinjected in C57BL/6 blastocyst and implanted in foster
mothers. The resulting germline chimeras were bred with C57BL/
6 (B6) to generate heterozygous mice for the targeted allele. F1
miR-10aneo/+ males were crossed to a ubiquitously expressing Cre
mouse line to eliminate the neo resistance cassette by Cre-LoxP
recombination. Mice carrying the miR-10a floxed allele (miR-10a2)
were intercrossed with B6 mice for at least 7 generations before
generating experimental cohorts of homozygous mutant and
control mice. All mice were genotyped by PCR using tail-tip DNA
and primers described in Figure 1A and Table S1, PCR conditions
were 95uC for 5 min followed by 35 cycles of denaturation at 95uC
for 30 sec, annealing at 56uC for 30 sec, extension at 72uC for
1 min and a final extension step at 72uC for 7 min.
ApcMin mice were obtained from The Jackson Laboratories and
are described elsewhere [27,28]. Only males were used for
breeding with miR-10a+/+ or miR-10a2/2 mice. Genotyping of the
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Min allele was performed by PCR using the primers APC.fw,
APC.rw and APC.Min under the same conditions described
above. All primer sequences are shown in Table S1.
Mice had free access to food and water.
Cell culture
HCT-116 cells were maintained in McCoy’s 5A medium
(Gibco) with 10% fetal bovine serum (Thermo Scientific) and 1%
penicillin/streptomycin (Invitrogen), incubated at 37uC in 5%
CO2.
Quantitative RT-PCR
Total RNA was isolated from mice tissues with TRIzol
(Invitrogen), as specified by the manufacturer, followed by DNase
I treatment with the DNA-free kit (Applied Biosystems). HCT-116
cells were seeded in 6-well plates and reversely transfected with
50 nM of Allstars negative control (Qiagen; cat:1027281), a miR-
10a duplex (Ambion; AM17100, PM10787) or siRNAs against
KLF4 (pool of two siRNAs with sequences: CCUUACACAUGAA-
GAGGCA[dT][dT], GUGGAUAUCAGGGUAUAAA[dT][dT],
25 nM each) using Lipofectamine2000 (Invitrogen). Cells were
harvested 48 h or 72 h post-transfection for total RNA extraction
using the miRNeasy Kit (Qiagen; 217004).
Mature miRNA specific qRT-PCR were performed using the
TaqMan miRNA Assays (Applied Biosystems) for mmu/hsa-miR-
10a and mmu/hsa-miR-10b; U6 small nuclear B non-coding RNA
(RNU6B) and miR-184 were used as endogenous controls for
normalization. For mRNA quantifications, first strand cDNA was
synthesized from total RNA with Multiscribe Reverse Transcriptase
(Applied Biosystems) and random hexamers. qRT-PCR was
performed with the Fast SYBR Green master mix (Applied
Biosystems) for KLF4 and Lpo mRNA and gene specific primers
are described in Table S3, ACTB, Ubc, 36b4 and Hprt was used for
normalization in mRNA relative quantifications. qRT-PCR for
human LPO was performed with the TaqMan Gene Expression
Assays (Applied Biosystems; AssayID: Hs00413417_m1) and ACTB
(AssayID: Hs03023943_g1) was used for normalization. All PCR
reactions were done in an Applied Biosystems 7900HT Fast Real-
Time PCR System using SDS software. The comparative CT
method was used for relative quantification of all RNA species
evaluated.
Adenoma scoring, histopathological analysis and
immunostaining
Mice were killed by CO2 asphyxiation or cervical dislocation.
Then entire intestinal tract was removed and gently washed with
cold PBS using a syringe before infusing them with 10% formalin;
samples were kept at 4uC before being analyzed. After washing in
PBS, intestines were opened lengthwise and examined under a
dissection microscope equipped with a graduated ocular graticule
at 206magnification for polyp counting and measurement. The
entire intestine was rolled and embedded in paraffin for further
histopathological and histochemical evaluation. Paraffin embed-
ded tissues were sectioned, rehydrated and stained using a
standard H&E staining protocol. H&E stained sections were
blindly examined for scoring of adenoma types and degree of
dysplasia based on pathological criteria.
For immunohistochemical detection of LPO a polyclonal
rabbit-anti-human LPO antibody (Thermo Fisher Scientific,
Rockford, USA, PA1-46353) was used diluted 1:200 where
chromogen staining was achieved using the EnVision+ system
(Dako, Glostrup, Denmark, K4003) in combination with No-
vaRED HRP substrate (VWR international, Herlev, Denmark,
SK-4800). Stained sections were scanned using a NanoZoomer-
2.0HT (Hamamatsu, Denmark) using 406 magnification.
Scanned sections were evaluated, blinded in respect to genotype
of mice, for low, medium or high Lpo expression. Comparison of
Lpo expression between miR-10a+/+ (n = 5) and miR-10a2/2
(n = 10) mice was done by Pearson Chi-square test with exact
probability and the analysis revealed a significant scoring
difference (P#0.006) between the two genotypes.
For immunohistochemical detection of Klf4 a polyclonal goat-
anti-mouse Klf4 antibody (R&D; AF3158) was used diluted 1:80
(2.5 mg/ml) where chromogen staining was achieved using the
EnVision+ system (Dako, Glostrup, Denmark, K4003) in combi-
nation with NovaRED HRP substrate (VWR international,
Herlev, Denmark, SK-4800), only 1/3 of normal hematoxylin
stain was used to prevent a too strong blue nuclear signal that
could bias the analysis. Stained sections were scanned using a
NanoZoomer-2.0HT (Hamamatsu, Denmark) using 406magni-
fication. To quantify the expression level of Klf4, whole scanned
sections were analyzed by the staining analysis software Visio-
morphDP, which is part of the Visiopharm software package
(Visiopharm, Hørsholm, Denmark). The formula Apositive/(Aposi-
tive+Anegative)*(255-Imean) was used as a measure of the Klf4
expression. Apositive = area of positive cells nuclei, Anegative = area of
Klf4 negative cell nuclei and Imean = the mean intensity value (0–
255, where the darkest colors have the lowest value) of the
separating color band (ref.). Comparison of Klf4 expression
between miR-10a+/+ (n = 5) and miR-10a2/2 (n = 8) mice was
done by Students t-test and the analysis revealed a significant
scoring difference (p = 0.019) between the two genotypes.
Microarray analysis
Total RNA was extracted from colon samples of 4 months old,
WT and miR-10a2/2 female mice. Organs were collected as
described in the previous section but after PBS washing, samples
were frozen in liquid nitrogen and kept at 280uC until RNA was
extracted. Four biological replicates of each genotype were
analyzed on Affymetrix microarrays (GeneChip Mouse Gene 1.0
ST Array) at the Microarray Centre, Rigshospitalet, Copenhagen
University Hospital as previously described [76].
Affymetrix probe set intensity of miR-10a KO and WT samples
were preprocessed using the aroma package in BioConductor,
including steps of background correction, normalization, and
summarization by RMA (Robust Multichip Average) method.
We then applied a non-specific filtering step to exclude those
genes showing low overall expression levels, as these genes were
unlikely to show down- or upregulation after miRNA transfection.
To do this, we required the interquartile range of probe set
expression levels to be greater than the first quartile value of the
interquartile range of expression levels for all probe sets. The
duplicated probe sets mapped to the same genes and the probe sets
without entrez gene annotation were also removed by this step. The
remaining probe sets were subsequently mapped to gene symbols
using the Affymetrix mogene10sttranscriptcluster.db annotation
Package. Differentially expressed genes were identified by a
moderated t-test with P-value less than 0.05 (452 transcripts and
annotation as listed in Table S2), using Limma [77] package in
Bioconductor. We defined three datasets: upregulated set (296
transcripts) with P-values#0.05 and log FC.0, upregulated set (156
transcripts) with P-values#0.05 and log FC,0, and no change set
containing 323 transcripts from the gene set with P-value near 1.
Western blot analysis
HCT-116 cells were seeded in 6-well plates and reverse
transfected with 50 nM Allstars negative control (Qiagen; Cat:
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1027281) or a miR-10a duplex (Ambion; AM17100, PM10787)
using Lipofectamine2000 (Invitrogen). Cells were harvested 72 h
post-transfection for protein extraction.
Cells or tissues were lysed and homogenized in RIPA buffer
(150 mM NaCl, 0.5% DOC, 0.1% SDS, 1% Igepal, 50 mM Tris-
HCl pH 8, 2 mM EDTA) containing 1 mM Pefabloc (Roche
Applied Science) and 16 Complete Mini protease inhibitor
mixture (Roche Applied Science). 20 mg of protein per lane from
was separated on a 4–12% NuPAGE Bis-Tris gel (Invitrogen) for
cell culture experiments and a 3–8% Tris-Acetate gel (Invitrogen)
for mouse tissues, followed by transfer to a nitrocellulose
membrane. Membranes were blocked in 5% milk for 40 min at
room temperature and incubated over night with primary
antibody at 4uC. Antibodies used were purchased from Santa
Cruz: LPO ((H-60) sc-134848), KLF4 ((H-180): sc-20691).
Luciferase reporter assays and vectors
A 1 kb sequence upstream the transcription start site of the LPO
genewas cloned into pGL4-luc2 (Promega) using the following primer
sequences (restriction sites NheI and XhoI are shown in lowercase
letters): Fwd: 59-TCgctagcTTTGCCTGGATTCATCAC-39, Rev:
59- TGctcgagCCTGAGCACATTTGTCCC-39. The KLF4 over
expressing vector was purchased from Addgene (pcDNA3.1-HA-
KLF4-FL; plasmid #34593). HCT-116 cells were seeded in 96-well
plates (15000 cells/well) and transfected the next day with 50 ng of
pGL4-luc2-LPO promoter or pGL4-luc2 (empty) and 50 ng of
pcDNA3.1-HA-KLF4-FL or pcDNA3.1+ (empty) using Lipofecta-
mine2000 (Invitrogen). Luciferase expression was measured 24 h
after transfection using the Dual-Glo luciferase assay (Promega,
E2940)). For investigating the potential miR-10a binding sites part of
the 59UTR of Lpo was cloned into psi-CHECK-2 (Promega) using
primers (restriction sites NheI is shown in lowercase letters):
Fwd-59UTR: 59-GACgctagcACATCAACTGCTCCCTGACAT-
CCT-39, Rev-59UTR: 59-CGTgctagcTAAAGGACACACACACT-
CAGGCTCA-39, and either the whole coding sequence (CDS) or a
609 bp sequence harboring the best miR-10a CDS binding site was
cloned into a Firefly luciferase fusion vector pPK-CMV-F4
(PromoKine) using primer sequences (restriction sites XhoI and
HindIII are shown in lowercase letters): Fwd-CDS: 59-GTGctcga-
gACCATGGTTAAAGTGCTTCTGCATCTCC-39 and Rev-
CDS: 59-CACaagcttTCCTTCACTGAGGCCCAGGGTG-39 and
Fwd-10a site: 59- GTGctcgagACCATGGTTATCTGTCAGAT-
TATCTCAAGC-39 and Rev-10a site: 59- CACaagcttTCCCCT-
GAGTCTTTAATTTAGGGTCACC-39. HCT-116 cells were
seeded in 96-well plates (15000 cells/well) and transfected the next
day with 30 nM of miR-10a mimic (Applied Biosystems; AM17100,
PM10787) or control (Qiagen; Allstars neg control: 1027281) and
100 ng of psi-CHECK-2-Lpo-59UTR alone, or 100 ng of pPK-
CMV-Lpo-CDS or pPK-CMV-Lpo-10a-site together with 10 ng
pRL-TK (Promega; Renilla vector used for normalization) using
Lipofectamine2000 (Invitrogen). Luciferase expression was measured
24 h after transfection using the Dual-Glo luciferase assay (Promega,
E2940)).
Supporting Information
Figure S1 Basic phenotypic characterization of miR-10a defi-
cient mice. (A) miR-10a2 allele segregation in the offspring of miR-
10a+/2 parents. (B) Weight of miR-10a+/+ (WT males n= 17,
females n = 24) and miR-10a2/2 (KO, males n= 21, females
n = 27) mice at 8 weeks of age. Detection of mature miR-10a (C)
and miR-10b (D) by qRT-PCR in intestines of miR-10a+/+ (WT)
and miR-10a2/2 (KO) mice. (E) Relative expression levels of
HoxB4 mRNA in intestines from mice of the indicated genotypes.
Circles represent values from female mice and squares represent
data from male mice. At least three different mice of each
genotype were analyzed in three independent experiments. Results
from one representative experiment are shown.
(TIF)
Figure S2 miR-10 expression levels in a panel of different
organs. miR-10a (A) and miR-10b (B) expression levels in different
organs of B6 mice as detected by qRT-PCR.
(TIF)
Figure S3 Relative expression levels of known miR-10a targets
and genes with oncogenic or tumor suppressor potential relevant
in intestinal tumorigenesis. mRNA levels were measured by qRT-
PCR using specific primers for miR-10a known targets (A) Usf2,
(B) HoxA3, (C) HoxD10, (D) Hdac4; Wnt/b-catenin pathway genes
(E) Cntb1, (F) Map3k7, (G) c-Jun, (H) Dvl3, (I) Sox2, (J) Ccnd1, (K) c-
Myc; Tgf-b signaling pathway genes (L) Tgfbr2, (M) Smad6, (N)
Smad7, (O) Pai1; and other important intestinal oncogenes (P) k-
Ras, (Q) Egfr, (R) Cox2. RNA samples from intestines of at least 4
different female mice were used in the analysis. All expression
values are relative to the housekeeping mRNA levels of Hprt.
(TIF)
Figure S4 Lpo is a secondary target of miR-10a. (A) Predicted
miR-10a binding sites in Lpo 59UTR and CDS. (B) Luciferase
reporter assay in HCT-116 cells (24 h) with constructs holding
either the Lpo coding sequence (CDS), part of Lpo CDS including
the best miR-10a putative binding site or the LPO 59UTR co-
transfected with a Renilla expressing vector along with a miR-10a
duplex or control. Data are shown as mean 6 S.D. of three
replicates relative to the control and are representative of three
independent experiments. n.s. using a two-tailed t-test. (C) Lpo
primary transcript levels, using primers in Lpo intron 9, and (D) Lpo
mature mRNA levels, using primers in Lpo exon 7 and 8, was
measured by qRT-PCR Actb was used for normalization and
values 6 SD are shown relative to the first WT sample.
(TIF)
Table S1 Probes and primers used for mouse genotyping.
(PDF)
Table S2 Deregulated genes in the intestines of miR-10a2/2mice.
452 genes up- or downregulated with an FDR smaller than 0.05
before correction are shown. Genes are ordered by Fold change.
(XLSX)
Table S3 Primers used in qRT-PCR.
(PDF)
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